2003
DOI: 10.1016/s0921-4410(03)21026-7
|View full text |Cite
|
Sign up to set email alerts
|

Genitourinary malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2005
2005
2006
2006

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 111 publications
0
2
0
Order By: Relevance
“…The concept of angiogenesis based therapy is well advocated in the literature and the development of both suppressors and inhibitors of angiogenesis has been proposed for the treatment of genitourinary malignancies [1][2][3][4][5][6][7][8][9][10][11].…”
Section: Discussionmentioning
confidence: 99%
“…The concept of angiogenesis based therapy is well advocated in the literature and the development of both suppressors and inhibitors of angiogenesis has been proposed for the treatment of genitourinary malignancies [1][2][3][4][5][6][7][8][9][10][11].…”
Section: Discussionmentioning
confidence: 99%
“…In metastatic renal cancer, breast cancer, and multiple myeloma, these agents have demonstrated reduction in skeletal events and bone pain. 76,77 In prostate cancer too, Hamdy and Papapoulos 78 reported that radionuclide therapy with bisphosphonates prolongs survival and slows the metastatic process. Moreover, Soerdjbalie-Maikoe et al 79 have demonstrated a reduction in the incidence of spinal cord compression in the hormone-resistant prostate cancer patients who received 89 Sr with the bisphosphonate olpadronate.…”
Section: New Therapeutic Developmentsmentioning
confidence: 99%